Skip to main content
. 2021 Jun 7;11:11949. doi: 10.1038/s41598-021-90570-3

Figure 6.

Figure 6

ALDH1 cytoplasmic expression in epithelia is upregulated in patients who ultimately develop endometrial cancer. ALDH1 expression was evaluated in epithelia from patients with (A) histologically normal endometrium, (B) hyperplasia without atypia and (C) atypical hyperplasia, with expression dichotomized into those who developed or did not develop cancer. Epithelial ALDH1 expression predicted increased likelihood of progression to developing cancer in patients with benign endometrium (p = 0.002) and hyperplasia (p = 0.02), but did not reach significance in atypical hyperplasia. (D) Kaplan–Meier plot showing time to progression to cancer for cytoplasmic ALDH1 expression in endometrial hyperplasia with or without atypia: the difference in median time to cancer diagnosis 145 months when ALDH1 negative vs 56 months when ALDH1 was positive, HR = 2.66, p = 7.1e−3.